Big Gain For Dermata Therapeutics Inc.
Thu, Aug 01, 2024 at 07:06 PM
Dermata Therapeutics Inc. (DRMA:NASDAQ) jumped higher at $2.48, a gain of 44.2%. On Thu, Aug 01, 2024, DRMA:NASDAQ touched a New 2-Week Intraday High of $2.73. The stock appeared on our News Catalysts scanner on Wed, Jul 17, 2024 at 10:05 AM in the 'BIOTECH' category. From Thu, Jul 18, 2024, the stock recorded 20.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Jul 24, 2024 at $5 with a volume of 65M+.
About Dermata Therapeutics Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 97.87%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 44.19%
- American Well Corporation Class A (AMWL:NYSE), 40.2%
- Next Technology Holding Inc. (NXTT:NASDAQ), 38.13%
- Agape ATP Corporation (ATPC:NASDAQ), 36.21%
- Omnicell, Inc. (OMCL:NASDAQ), 33%
- Sacks Parente Golf Inc. (SPGC:NASDAQ), 30.23%
- Exact Sciences Corporation (EXAS:NASDAQ), 26.77%
- Armada Acquisition Corp. I (AACI:NASDAQ), 25.3%